Insider Transactions in Q4 2024 at Globus Medical Inc (GMED)
Insider Transaction List (Q4 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 02
2024
|
Kelly Huller SVP, GC, Corporate Secretary |
SELL
Open market or private sale
|
Direct |
2,500
-100.0%
|
$217,500
$87.0 P/Share
|
|
Dec 02
2024
|
Kelly Huller SVP, GC, Corporate Secretary |
BUY
Exercise of conversion of derivative security
|
Direct |
2,500
+50.0%
|
$60,000
$24.21 P/Share
|
|
Nov 22
2024
|
David D Davidar |
SELL
Open market or private sale
|
Indirect |
6,746
-3.91%
|
$573,410
$85.0 P/Share
|
|
Nov 22
2024
|
David D Davidar |
SELL
Open market or private sale
|
Direct |
6,766
-1.29%
|
$575,110
$85.0 P/Share
|
|
Nov 22
2024
|
Dan Lemaitre |
SELL
Open market or private sale
|
Direct |
1,097
-100.0%
|
$93,245
$85.02 P/Share
|
|
Nov 22
2024
|
Dan Lemaitre |
BUY
Exercise of conversion of derivative security
|
Direct |
1,097
+50.0%
|
$71,305
$65.05 P/Share
|
|
Nov 21
2024
|
David D Davidar |
SELL
Open market or private sale
|
Indirect |
13,254
-7.13%
|
$1,126,590
$85.0 P/Share
|
|
Nov 21
2024
|
David D Davidar |
SELL
Open market or private sale
|
Direct |
13,234
-2.47%
|
$1,124,890
$85.0 P/Share
|
|
Nov 21
2024
|
Dan Lemaitre |
SELL
Open market or private sale
|
Direct |
13,278
-100.0%
|
$1,128,630
$85.0 P/Share
|
|
Nov 21
2024
|
Dan Lemaitre |
BUY
Exercise of conversion of derivative security
|
Direct |
13,278
+50.0%
|
$863,070
$65.05 P/Share
|
|
Nov 21
2024
|
Daniel T Scavilla President, CEO |
SELL
Open market or private sale
|
Direct |
130,000
-100.0%
|
$11,050,000
$85.0 P/Share
|
|
Nov 21
2024
|
Daniel T Scavilla President, CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
130,000
+44.05%
|
$5,590,000
$43.68 P/Share
|
|
Nov 15
2024
|
David C Paul Executive Chairman |
BUY
Exercise of conversion of derivative security
|
Direct |
26,042
+50.0%
|
$625,008
$24.1 P/Share
|
|
Nov 06
2024
|
Kelly Huller SVP, GC, Corporate Secretary |
SELL
Open market or private sale
|
Direct |
5,000
-75.0%
|
$405,000
$81.01 P/Share
|
|
Nov 06
2024
|
Kelly Huller SVP, GC, Corporate Secretary |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+50.0%
|
$120,000
$24.21 P/Share
|
|
Nov 06
2024
|
Daniel T Scavilla President, CEO |
SELL
Open market or private sale
|
Direct |
60,000
-100.0%
|
$4,800,000
$80.02 P/Share
|
|
Nov 06
2024
|
Daniel T Scavilla President, CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
60,000
+41.67%
|
$2,100,000
$35.02 P/Share
|
|
Oct 16
2024
|
Kelly Huller SVP, GC, Corporate Secretary |
SELL
Open market or private sale
|
Direct |
7,500
-100.0%
|
$562,500
$75.02 P/Share
|
|
Oct 16
2024
|
Kelly Huller SVP, GC, Corporate Secretary |
BUY
Exercise of conversion of derivative security
|
Direct |
7,500
+50.0%
|
$187,500
$25.8 P/Share
|
|
Oct 16
2024
|
David D Davidar |
SELL
Open market or private sale
|
Indirect |
20,000
-9.71%
|
$1,500,000
$75.03 P/Share
|
|
Oct 16
2024
|
David D Davidar |
SELL
Open market or private sale
|
Direct |
30,000
-5.3%
|
$2,250,000
$75.04 P/Share
|